Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shang‐Ying Hu
Efficacy, Immunogenicity and Safety of the AS04‐HPV‐16/18 Vaccine in Chinese Women Aged 18‐25 Years: End‐of‐study Results From a Phase II/III, Randomised, Controlled Trial
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
477. Phase I Safety and Immunogenicity of HPV 16 and 18 DNA Vaccines Delivered via Electroporation
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Erratum To: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
Open Forum Infectious Diseases
Oncology
Neurology
Risk of Miscarriage With Bivalent Vaccine Against Human Papillomavirus (HPV) Types 16 and 18: Pooled Analysis of Two Randomised Controlled Trials
BMJ
Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults Aged 18–60 Years
Epidemiology and Vaccine Prevention
The Effect of Comprehensive Classes of Health Aerobics on Women Aged 18-25 Years
GTL001, a Therapeutic Vaccine for Women Infected With Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Clinical Cancer Research
Cancer Research
Oncology
Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
Drugs
Pharmacology
Preschoolers in the Playground: A Pilot Cluster Randomised Controlled Trial of a Physical Activity Intervention for Children Aged 18 Months to 4 Years
Public Health Research
